TFC BioSciences
Norwood
About TFC BioSciences
TFC BioSciences develops and manufactures liposome-based fluorescence detection systems – Fluorosomes® – for applications in drug discovery and related fields. Utilizing the Fluorosome® platform they are continuously expanding their technology to develop smart tools for “ADMET” studies in drug discovery.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Last round: Grant (Nov 2014)
- Website: tfcbio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Manufacturing
Canonical: https://fsome.com/organization/tfc-biosciences-3154021 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.